Neovascular Age-Related Macular Degeneration

Also known as: Neovascular Age-related Macular Degeneration / Exudative Age-related Macular Degeneration / Kuhnt Junius degeneration / Disciform macular degeneration / Exudative senile macular degeneration of retina

DrugDrug NameDrug Description
DB04895PegaptanibA selective vascular endothelial growth factor (VEGF) antagonist used for the treatment of neovascular (wet) age-related macular degeneration.
DrugDrug NameTargetType
DB04895PegaptanibNeuropilin-1target
DrugDrug NamePhaseStatusCount
DB08885Aflibercept1Completed2
DB08885Aflibercept1Not Yet Recruiting1
DB08885Aflibercept1Recruiting2
DB14131Basic Fibroblast Growth Factor1Recruiting1
DB00112Bevacizumab1Completed1
DB00112Bevacizumab1Recruiting1
DB00112Bevacizumab1Withdrawn1
DB15330Nesvacumab1Completed1
DB01270Ranibizumab1Completed2
DB08885Aflibercept1 / 2Completed2
DB08885Aflibercept1 / 2Recruiting1
DB03006Arsanilic acid1 / 2Recruiting1
DB14864Brolucizumab1 / 2Completed1
DB01234Dexamethasone1 / 2Completed1
DB01270Ranibizumab1 / 2Completed3
DB01268Sunitinib1 / 2Completed1
DB08885Aflibercept2Completed3
DB08885Aflibercept2Not Yet Recruiting1
DB08885Aflibercept2Recruiting1
DB08885Aflibercept2Terminated2
DB00112Bevacizumab2Completed1
DB00112Bevacizumab2Not Yet Recruiting1
DB00112Bevacizumab2Terminated1
DB00112Bevacizumab2Unknown Status1
DB14864Brolucizumab2Completed3
DB15330Nesvacumab2Completed1
DB08888Ocriplasmin2Completed1
DB01270Ranibizumab2Completed6
DB01270Ranibizumab2Recruiting1
DB01270Ranibizumab2Terminated1
DB06305Sonepcizumab2Completed1
DB00421Spironolactone2Completed1
DB01268Sunitinib2Recruiting1
DB11926Tesidolumab2Terminated1
DB00460Verteporfin2Unknown Status1
DB00869Dorzolamide2 / 3Recruiting1
DB00373Timolol2 / 3Recruiting1
DB08885Aflibercept3Completed4
DB08885Aflibercept3Recruiting2
DB00112Bevacizumab3Active Not Recruiting1
DB00112Bevacizumab3Recruiting1
DB00112Bevacizumab3Unknown Status2
DB14864Brolucizumab3Completed3
DB12460Conbercept3Recruiting2
DB01270Ranibizumab3Active Not Recruiting2
DB01270Ranibizumab3Completed2
DB01270Ranibizumab3Recruiting2
DB01270Ranibizumab3Terminated1
DB00620Triamcinolone3Unknown Status2
DB00460Verteporfin3Unknown Status1
DB08885Aflibercept4Active Not Recruiting2
DB08885Aflibercept4Completed5
DB08885Aflibercept4Not Yet Recruiting1
DB00112Bevacizumab4Completed1
DB11059Carboxymethylcellulose4Enrolling by Invitation1
DB06802Nepafenac4Enrolling by Invitation1
DB04895Pegaptanib4Withdrawn1
DB01270Ranibizumab4Active Not Recruiting1
DB01270Ranibizumab4Completed8
DB01270Ranibizumab4Recruiting1
DB08885AfliberceptNot AvailableCompleted1
DB08885AfliberceptNot AvailableWithdrawn1
DB00126Ascorbic acidNot AvailableUnknown Status1
DB00112BevacizumabNot AvailableCompleted4
DB04335InosineNot AvailableUnknown Status1
DB00151L-CysteineNot AvailableUnknown Status1
DB01017MinocyclineNot AvailableUnknown Status1
DB02701NicotinamideNot AvailableUnknown Status1
DB04895PegaptanibNot AvailableCompleted2
DB01270RanibizumabNot AvailableUnknown Status1
DB11251TocopherolNot AvailableUnknown Status1
DB12647TocotrienolNot AvailableUnknown Status1
DB00620TriamcinoloneNot AvailableWithdrawn1
DB09270UbidecarenoneNot AvailableUnknown Status1
DB00460VerteporfinNot AvailableWithdrawn1